Try our Advanced Search for more refined results

March 08, 2010

Merck, Sharp & Dohme Corp. et al v. Teva Pharmaceuticals USA, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 06, 2013

    Teva Settles With BMS, Merck Over HIV Drug Generic Plans

    Teva Pharmaceuticals Industries Ltd. on Wednesday agreed to a settlement with Bristol-Myers Squibb Co. and Merck Sharp & Dohme Corp., ending claims in New York federal court that its planned generic version of HIV treatment Atripla had infringed two patents.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!